These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 12376521)
21. 249ser p53 mutation in the serum of black southern African patients with hepatocellular carcinoma. Kimbi GC; Kew MC; Yu MC; Arakawa K; Hodkinson J J Gastroenterol Hepatol; 2005 Aug; 20(8):1185-90. PubMed ID: 16048565 [TBL] [Abstract][Full Text] [Related]
22. P53 codon 249 mutation in hepatocellular carcinomas from Nigeria. Ndububa DA; Yakicier CM; Ojo OS; Adeodu OO; Rotimi O; Ogunbiyi O; Ozturk M Afr J Med Med Sci; 2001; 30(1-2):125-7. PubMed ID: 14510167 [TBL] [Abstract][Full Text] [Related]
23. Analysis of the p53 gene in European hepatocellular carcinomas and hepatoblastomas. Debuire B; Paterlini P; Pontisso P; Basso G; May E Oncogene; 1993 Aug; 8(8):2303-6. PubMed ID: 8393166 [TBL] [Abstract][Full Text] [Related]
24. [p53 gene codon 72 polymorphism and genetic susceptibility to hepatocellular carcinoma in Chinese population]. Zhu ZZ; Cong WM; Liu SF; Dong H; Zhu GS; Wu MC Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):76-9. PubMed ID: 15774209 [TBL] [Abstract][Full Text] [Related]
25. [Sequence alterations in p53 gene of hepatocellular carcinoma from high aflatoxin risk area in Guangxi]. Deng Z; Pan L; Ma Y Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):18-21. PubMed ID: 10743047 [TBL] [Abstract][Full Text] [Related]
26. Clinical significance of aflatoxin, mutant P53 gene and sIL-2 receptor in liver cirrhosis and hepatocellular carcinoma. El-Shanawani FM; Abdel-Hadi AA; Abu Zikri NB; Ismail A; El-Ansary M; El-Raai A J Egypt Soc Parasitol; 2006 Apr; 36(1):221-39. PubMed ID: 16605112 [TBL] [Abstract][Full Text] [Related]
27. Detection of hotspot mutations and polymorphisms using an enhanced PCR-RFLP approach. Liu WH; Kaur M; Makrigiorgos GM Hum Mutat; 2003 May; 21(5):535-41. PubMed ID: 12673796 [TBL] [Abstract][Full Text] [Related]
28. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries. Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820 [TBL] [Abstract][Full Text] [Related]
29. Ser-249 TP53 and CTNNB1 mutations in circulating free DNA of Egyptian patients with hepatocellular carcinoma versus chronic liver diseases. Hosny G; Farahat N; Tayel H; Hainaut P Cancer Lett; 2008 Jun; 264(2):201-8. PubMed ID: 18313840 [TBL] [Abstract][Full Text] [Related]
30. The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts. Denissenko MF; Koudriakova TB; Smith L; O'Connor TR; Riggs AD; Pfeifer GP Oncogene; 1998 Dec; 17(23):3007-14. PubMed ID: 9881702 [TBL] [Abstract][Full Text] [Related]
31. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis]. Xue KX Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497 [TBL] [Abstract][Full Text] [Related]
32. Mutation at codon 249 of p53 gene in a human hepatoblastoma. Kar S; Jaffe R; Carr BI Hepatology; 1993 Sep; 18(3):566-9. PubMed ID: 8395458 [TBL] [Abstract][Full Text] [Related]
33. Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand. Kuang SY; Lekawanvijit S; Maneekarn N; Thongsawat S; Brodovicz K; Nelson K; Groopman JD Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):380-4. PubMed ID: 15734961 [TBL] [Abstract][Full Text] [Related]
34. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect. Marotta F; Vangieri B; Cecere A; Gattoni A Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567 [TBL] [Abstract][Full Text] [Related]
36. Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China. Su H; Zhao J; Xiong Y; Xu T; Zhou F; Yuan Y; Zhang Y; Zhuang SM Mutat Res; 2008 May; 641(1-2):27-35. PubMed ID: 18358501 [TBL] [Abstract][Full Text] [Related]
37. Absence of TP53 codon 249 mutations in young Guinean children with high aflatoxin exposure. Turner PC; Sylla A; Kuang SY; Marchant CL; Diallo MS; Hall AJ; Groopman JD; Wild CP Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2053-5. PubMed ID: 16103461 [TBL] [Abstract][Full Text] [Related]
38. A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection. Zhu ZZ; Cong WM; Liu SF; Xian ZH; Wu WQ; Wu MC; Gao B; Hou LF; Zhu GS Cancer Lett; 2005 Nov; 229(1):77-83. PubMed ID: 15979781 [TBL] [Abstract][Full Text] [Related]
39. P53 gene of chang-liver cells (Atcc-Ccl13) exposed to aflatoxin B1 (Afb): the effect of lysine on mutation at codon 249 of exon 7. Uwaifo O Afr J Med Med Sci; 1999; 28(1-2):71-5. PubMed ID: 12953991 [TBL] [Abstract][Full Text] [Related]
40. An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico. Soini Y; Chia SC; Bennett WP; Groopman JD; Wang JS; DeBenedetti VM; Cawley H; Welsh JA; Hansen C; Bergasa NV; Jones EA; DiBisceglie AM; Trivers GE; Sandoval CA; Calderon IE; Munoz Espinosa LE; Harris CC Carcinogenesis; 1996 May; 17(5):1007-12. PubMed ID: 8640905 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]